Gilead and Roche the dreater and manufacturer of tamiflu respectively, have come to an agreement over money and royalties for the drug.
sanfrancisco.bizjournals.com...
Foster City-based Gilead won't pay Roche any more for making the drug, but Roche will keep paying Gilead (NASDAQ:GILD) royalties of 14 percent to 22 percent on sales of the drug.
Gilead said in June it would end its deal with Roche. It fought to get back rights to the drug, saying Roche hadn't lived up to its end of the deal and was behind on royalty payments. The two companies went into mediation three months later.
As part of the deal announced Wednesday, Gilead has also gotten an option to co-promote Tamiflu in some parts of the United States, though it won't do so in 2006
Meanwhile scientists are calling out for more investigation and testing of Tamiflu after some alarming cases came to light this week of suicides and other possible side affects of the drug
www.alertnet.org...
LONDON, Nov 16 (Reuters) - More research is needed to find the optimal dose of anti-flu drug Tamiflu for use in the event of a possible pandemic triggered by bird flu, a U.S. expert on the disease said on Wednesday.
Dr John Beigel of the National Institutes of Health said Roche Holding AG'smedicine remained the best available treatment but doctors needed better evidence-based guidance on its use.
"Good rigorous data is lacking," Beigel told a bird flu conference organised by investment bank UBS.
Beigel said he was currently working with Roche to develop a new clinical trial programme designed to ascertain optimal dosing.
The current recommended dose is two 75 milligram pills a day for five days.
All the clinical studies so far on Tamiflu have been conducted in developed countries among relatively healthy people, leaving it unclear whether critically ill patients should receive a different dose, Beigel said.
Some animal research suggested that the highly pathogenic H5N1 strain of bird flu now circulating in parts of Asia might require more of the drug to bring it under control than flu types found in 1997, he added.
=====================================================
News Update = China
China has reported that the brotehr of the 12 year old girl who died last month of suspected Bird Flu has tested positive to the disease. China has also reported other human cases, the first reports of human cases within the country.
Monsters And Critics
The H5N1 virus was detected in three patients, two in the central province of Hunan and one in the eastern province of Anhui, the ministry said.
The infected patient from Anhui was not one of those previously suspected of having the virus.
All three were believed to have caught the virus through contact with sick birds.
The World Health Organization (WHO) had investigated three suspected cases of bird flu in Hunan with the authorities. One of the three, a 12-year-old girl, died.
The girl was cremated before enough blood was taken to confirm if she had the virus, WHO spokesman Roy Wadia said.
WHO said that blood taken from the nine-year-old brother contained bird-flu antibodies, a 'clear sign' of an infection with the deadly H5N1 strain of the virus.
The third person suspected of having bird flu in Hunan was a male teacher, 36, who, like the brother and sister, had close contact with infected chickens.
[edit on 16-11-2005 by Mayet]



